Latest: Abzena Launches EpiScreen® 2.0 Immunogenicity Platform | Learn more
- About
- Main Menu
- Main Menu
- Leadership Team
- Our History
- Locations
- Capabilities
- Main Menu
- Main Menu
- Bioconjugates & Chemistry
- Biologics
- Resources
- Careers
- Contact
During DCAT Week 2024, Life Science Knowledge Hub sat down with Abzena’s VP of Cell Line Development, Simon Keen, to find out more about the exciting world of our AbZelect and AbZelectPRO cell line development platform and its impact on the biopharmaceutical industry. Simon will shed light on the platform’s capabilities and address some key questions related to its implementation.